TETRALOGIC PHARMACEUTICALS CORP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases
TETRALOGIC PHARMACEUTICALS CORP reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases of $32.30 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-16.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases · last filed 2016-03-16
- TETRALOGIC PHARMACEUTICALS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2014-12-31 was $6.66M.
- TETRALOGIC PHARMACEUTICALS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2014-09-30 was $0.00.
- TETRALOGIC PHARMACEUTICALS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2014 was $32.30M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 12 month |
|---|---|---|---|---|
| 2014-12-31 | $6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $6.66M derived: sum of 2 quarters · filed 2016-03-16 | $32.30M 10-K · filed 2016-03-16 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $25.64M 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | $25.64M 10-Q · filed 2015-08-05 |